[Small doses of the resin Colestid in the treatment of hyperlipoproteinemia].

Author: GrafnetterD, JirkovskáA, VálekJ

Paper Details 
Original Abstract of the Article :
To a group of 24 subjects with hypercholesterolaemia (hyperlipoproteinaemia type II) for a period of three months the non-absorbable resin Colestid was administered in order to reduce levels of atherogenic lipids and lipoproteins. The Colestid doses were graded from 5 g in the first month to 10-15 g...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/2004412

データ提供:米国国立医学図書館(NLM)

Small Doses for Big Results: A Look at Colestid for Hyperlipoproteinemia

This study explores the effectiveness of Colestid, a non-absorbable resin, in managing hyperlipoproteinemia, a condition that can be as perplexing as a shifting desert landscape. The research, much like a meticulous caravan organizer, carefully monitored 24 individuals with hypercholesterolemia over three months, adjusting the dose of Colestid to find the optimal balance. The findings, like a glistening oasis in the arid landscape, revealed that even small doses of Colestid significantly reduced cholesterol levels, suggesting a promising approach to managing this complex condition.

A Gentle Approach to Lipid Management

This research highlights the potential of Colestid as a safe and effective treatment option for hyperlipoproteinemia. The researchers, like experienced desert guides, demonstrated that small doses of Colestid can effectively lower cholesterol levels without causing significant side effects.

A Balancing Act: Managing Lipid Levels

This research underscores the importance of finding the right balance when it comes to managing lipid levels. The study serves as a reminder that there's no one-size-fits-all approach, and carefully tailored treatment plans are key to achieving optimal health outcomes.

Dr.Camel's Conclusion

This research demonstrates the power of careful observation and dose titration in managing hyperlipoproteinemia. By taking a measured approach, similar to the way a desert traveler conserves precious resources, we can effectively manage lipid levels and improve health outcomes.
Date :
  1. Date Completed 1991-04-25
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

2004412

DOI: Digital Object Identifier

2004412

Related Literature

SNS
PICO Info
in preparation
Languages

Czech

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.